• Kirk Hartley

The Gene Patent Wars Continue – Myriad Files Suit to Enjoin BRACA Testing

The Myriad decision was supposed to end Myriad’s stranglehold on testing for mutations of BRACA genes. The patent was illegal because genes are not patentable. The patent was inequitable because Myriad was merely one of several research groups involved in the ultimately successful effort to find the BRACA genes.

Unfortunately, SCOTUS did not write sweepingly enough, and so Myriad’s patent lawyers are now back with a lawsuit trying to enjoin BRACA gene testing by at least one lab that started up BRACA testing after the Myriad decision. Other labs, apparently, are still testing, at least for now. The lawsuit is reported in some detail at Patent Docs.

#Cancer

0 views0 comments

Recent Posts

See All

Glyphosate Litigation Starts Up In Australia

The litigation industry is global. The latest example is the start of RoundUp/glyphosate litigation in Australia, as described in this June 3,  2019 article in the Brisbane Times.